Detalles de la búsqueda
1.
Prognostic value of myocardial perfusion scintigraphy in asymptomatic patients with diabetes mellitus at high cardiovascular risk: 5-year follow-up of the prospective multicenter BARDOT trial.
Eur J Nucl Med Mol Imaging
; 48(11): 3512-3521, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33884468
2.
Do ultrathin strut bare-metal stents with passive coating improve efficacy in large coronary arteries? Insights from the randomized, multicenter BASKET-PROVE trials.
BMC Cardiovasc Disord
; 19(1): 226, 2019 10 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31619181
3.
Second generation drug-eluting stents versus bare-metal stents for percutaneous coronary intervention of the proximal left anterior descending artery: An analysis of the BASKET-PROVE I and II trials.
Catheter Cardiovasc Interv
; 91(5): 867-873, 2018 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28722266
4.
N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF.
J Card Fail
; 23(5): 382-389, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28232046
5.
Quality of life as predictor for the development of cardiac ischemia in high-risk asymptomatic diabetic patients.
J Nucl Cardiol
; 24(3): 772-782, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28091969
6.
Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial.
Circulation
; 131(1): 74-81, 2015 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-25411159
7.
Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial.
Am Heart J
; 173: 1-7, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26920590
8.
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.
N Engl J Med
; 366(1): 20-33, 2012 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-22077816
9.
Improved outcomes of elderly patients treated with drug-eluting versus bare metal stents in large coronary arteries: results from the BAsel Stent Kosten-Effektivitäts Trial PROspective Validation Examination randomized trial.
Am Heart J
; 170(4): 787-795.e1, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26386803
10.
Differential prognostic impact of resting heart rate in older compared with younger patients with chronic heart failure--insights from TIME-CHF.
J Card Fail
; 21(4): 347-54, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25576682
11.
Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis.
Eur Heart J
; 35(23): 1559-67, 2014 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-24603309
12.
Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations.
Am Heart J
; 168(5): 698-705, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25440798
13.
Interaction between pulmonary hypertension and diastolic dysfunction in an elderly heart failure population.
J Card Fail
; 20(2): 98-104, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24361805
14.
Duration of dual antiplatelet therapy after drug-eluting stents.
N Engl J Med
; 372(14): 1372, 2015 04 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-25830433
15.
Drug-eluting versus bare-metal stents in large coronary arteries.
N Engl J Med
; 363(24): 2310-9, 2010 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-21080780
16.
Stent thrombosis after coronary stent implantation: a protective effect of high-dose statin therapy?
Cardiology
; 126(2): 115-21, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23948958
17.
End-of-life preferences of elderly patients with chronic heart failure.
Eur Heart J
; 33(6): 752-9, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22067089
18.
Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy.
Am Heart J
; 163(3): 407-14, 414.e1, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22424011
19.
Newest-generation drug-eluting and bare-metal stents combined with prasugrel-based antiplatelet therapy in large coronary arteries: the BAsel Stent Kosten Effektivitäts Trial PROspective Validation Examination part II (BASKET-PROVE II) trial design.
Am Heart J
; 163(2): 136-41.e1, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22305828
20.
Letter by Jeger and Pfisterer regarding article, "prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement".
Circulation
; 132(13): e165, 2015 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26416638